Maxion Therapeutics
ID: 13756874Developer of antibody-based KnotBody® drugs for ion channel- and G protein coupled receptor (GPCR)-driven diseases.
2
Funding Rounds
$88.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Mc******** |
|
- | |
| An**** Ka**** Ve***** |
|
- |
Funding series
Funding Series Analysis
The company Maxion Therapeutics has raised a total of $72m in funding over 2 rounds.
Key Insights:
- Maxion Therapeutics Series A Round, March 2025: $72m
- Maxion Therapeutics Series A round, February 19, 2023: $16m